Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.30%
1,086.03
+3.23
+0.30%
—1,082.801,079.311,089.311,079.31——
SIXC
Communications
SIXC
Communications
SIXC
+1.14%
610.65
+6.88
+1.14%
—603.77603.77611.65602.09——
SIXE
Energy
SIXE
Energy
SIXE
-1.91%
1,188.06
-23.13
-1.91%
—1,211.191,203.051,203.051,182.72——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.14%
1,753.60
-2.39
-0.14%
—1,755.991,759.061,760.661,747.23——
SIXM
Financials
SIXM
Financials
SIXM
+0.04%
638.72
+0.21
+0.04%
—638.51637.93640.10634.21——
SIXR
Staples
SIXR
Staples
SIXR
+1.56%
856.08
+13.12
+1.56%
—842.96843.54857.93843.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.45%
220.26
+0.98
+0.45%
—219.28219.28220.58218.64——
SIXT
Technology
SIXT
Technology
SIXT
-0.67%
3,703.52
-24.83
-0.67%
—3,728.353,745.063,745.063,677.88——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.56%
910.37
-5.11
-0.56%
—915.48914.49915.84907.90——
SIXV
Health care
SIXV
Health care
SIXV
+0.64%
1,506.93
+9.57
+0.64%
—1,497.361,500.651,514.701,495.89——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+2.05%
2,462.65
+49.48
+2.05%
—2,413.172,431.692,463.212,431.69——
ARQT:NASDAQ
Arcutis Biotherapeutics Inc
$21.79
+3.22%
(+0.68) 1D
May 27, 10:45:15 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARQT...
Open
$21.33
High
$22.06
Low
$21.24
Mkt. cap
2.71B
Avg. vol.
1.80M
Volume
221.28K
52-wk high
$31.77
52-wk low
$12.72
EPS
-$0.02
Beta
1.58
Shares outstanding
125.08M
No. of employees
354
News stories
From sources across the web
About Arcutis Biotherapeutics Inc
CEOFrank Watanabe
Employees354
Founded2016
HeadquartersWestlake Village, California, United States
SectorBiotechnology
Websitearcutis.com
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.09 / -$0.06
-55.17%miss
Revenue / Est. (USD)
105.40M / 103.66M
+1.68%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
81.50M
99.22M
129.50M
105.40M
Cost of goods sold
7.49M
8.68M
11.69M
9.78M
Cost of revenue
7.49M
8.68M
11.69M
9.78M
Research and development expenses
19.45M
19.60M
20.45M
30.63M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
69.17M
62.40M
78.98M
74.08M
Operating expense
88.62M
82.01M
99.43M
104.70M
Total operating expenses
96.12M
90.69M
111.12M
114.49M
Operating income
-14.61M
8.53M
18.39M
-9.09M
Other non operating income
-
-
443.00K
-20.00K
EBT including unusual items
-15.54M
7.49M
17.86M
-11.20M
EBT excluding unusual items
-15.54M
7.49M
17.86M
-11.20M
Income tax expense
342.00K
80.00K
470.00K
93.00K
Effective tax rate
-2.20%
1.07%
2.63%
-0.83%
Other operating expenses
-
-
-
-
Net income
-15.89M
7.41M
17.40M
-11.30M
Net profit margin
-19.49%
7.47%
13.43%
-10.72%
Earnings per share
-0.13
0.06
0.13
-0.09
Interest and investment income
2.10M
2.04M
2.04M
2.28M
Interest expense
-3.03M
-3.07M
-3.00M
-4.37M
Net interest expenses
-933.00K
-1.04M
-965.00K
-2.09M
Depreciation and amortization charges
-
-
-
-
EBITDA
-14.20M
9.09M
18.95M
-8.53M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer